arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

Pluri Inc.

PLUR
$1.11 ▲ +0.03 (+2.78%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
18 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
85
Health
Excellent
Bullish
auto_awesome

Analytical Summary

Pluri Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $10.8M
Dividend Yield
Revenue Growth -24.0%
Op. Margin
ROIC 108.2%
FCF / Share $-2.08
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 22, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.02M
↓ -24.0%
Net Income Profit after all expenses
$-23.82M
↓ -5.5%
FCF / Share Free cash flow per share
$-2.08
↑ +33.7%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns
98
Cash Quality
51

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 66 quarters